High expression of PMEPA1 (isoform -a) was detected in estrogen receptor/progesterone receptor–negative and human epidermal growth factor receptor-2–negative breast cancer cell lines and primary breast cancers and this expression is increased by TGF-β treatment [29]. Here, PMEPA1 is linked to breast carcinoma.